GCS tech(SZ:002453) Zheng Quan Zhi Xing·2025-08-27 13:16Core Viewpoint - The company announced a capital increase for its wholly-owned subsidiary, Cangzhou Aodexi Chemical Co., Ltd., through a debt-to-equity swap, aimed at improving the subsidiary's capital structure [1][5]. Summary by Sections Capital Increase Overview - The company’s subsidiary, Beijing Aodexi Chemical Co., Ltd., will convert its debt of 130 million yuan into equity, increasing its investment in Cangzhou Aodexi to 150 million yuan, which will represent 100% of Cangzhou Aodexi's registered capital [1][5]. Basic Information of the Capital Increase Target - Cangzhou Aodexi Chemical Co., Ltd. is a limited liability company established on December 9, 2015, with a registered capital of 20 million yuan. The company is located in Cangzhou Lingang Development Zone and is wholly owned by Beijing Aodexi [3]. Financial Status - As of the latest audited figures, Cangzhou Aodexi has total assets of 160.45 million yuan and total liabilities of 194.47 million yuan, resulting in a net asset deficit of 34.03 million yuan. The company reported an operating income of 78.38 million yuan and a net loss of 23.75 million yuan [4][5]. Impact of the Capital Increase - The capital increase is expected to improve Cangzhou Aodexi's asset-liability structure, promoting sustainable operations and aligning with the company's overall development strategy. The subsidiary will remain a wholly-owned subsidiary post-increase, with no adverse effects on the company's financial and operational status [5].